Editorial HIV/AIDS Pediatrics
Effect of point-of-care ultrasound on 30-day readmission among adults with type 2 diabetes

Effect of point-of-care ultrasound on 30-day readmission among adults with type 2 diabetes

Authors

Omar Patel

Omar Patel

Hamad Medical Corporation, Virgin Islands (US)

Adam Zhang

Adam Zhang

Charité Berlin, Oman

Daniel Andersen

Daniel Andersen

Toronto General Hospital, Mauritania

Tariq Rahman

Tariq Rahman

Toronto General Hospital, Costa Rica

Ines Ibrahim

Ines Ibrahim

Aga Khan University Hospital, Macau S.A.R.

Malik Nasser

Malik Nasser

American University of Beirut Medical Center, Saint Kitts and Nevis

Corresponding

Published

April 17, 2026

Paper ID

PAP-000105

Status

Published

DOI

10.65712/tmj.test000363

Effect of point-of-care ultrasound on 30-day readmission among adults with type 2 diabetes

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: The cost of 30-day readmission to health systems is substantial. Methods: Eligible participants were adults with type 2 diabetes. Results: 30-day readmission occurred in 17% of the intervention group versus 36% of controls. 3541 participants were included (median age 70 years). Conclusion: Future work should test point-of-care ultrasound in a pragmatic multicentre trial.

References

1. Moreau S, Okafor O, et al. Point-of-care ultrasound and post-operative delirium. Crit Care Med. 2015;383(11):190-948.

2. Mueller P, Yilmaz V, et al. High-flow nasal oxygen and emergency department revisits. Eur Heart J. 2020;348(7):29-1550.

3. Rahman Z, Zhang T, et al. A sepsis alert system and ventilator-free days. JAMA. 2014;198(6):483-1417.

4. Costa Y, Ahmed F, et al. An enhanced recovery pathway and 30-day readmission. Lancet. 2023;110(11):457-1306.

5. Ahmed H, Rahman V, et al. Frailty screening and time to diagnosis. N Engl J Med. 2013;82(7):621-1645.

6. Novak I, Ibrahim P, et al. SGLT2 inhibitors and time to diagnosis. Pediatrics. 2014;388(6):663-1537.

Introduction

The cost of 30-day readmission to health systems is substantial. Practice around point-of-care ultrasound varies widely between centres.

Practice around point-of-care ultrasound varies widely between centres. 30-day readmission remains a leading cause of avoidable harm among adults with type 2 diabetes.

30-day readmission remains a leading cause of avoidable harm among adults with type 2 diabetes. Earlier studies of point-of-care ultrasound were small or single-centre.

Materials and Methods

Missing data were handled with multiple imputation. Eligible participants were adults with type 2 diabetes. We conducted a systematic review and meta-analysis across 9 centres between 2015 and 2022.

The primary outcome was 30-day readmission, assessed blind to allocation. Analyses were adjusted for age, sex and baseline severity. Eligible participants were adults with type 2 diabetes.

The primary outcome was 30-day readmission, assessed blind to allocation. Missing data were handled with multiple imputation. Eligible participants were adults with type 2 diabetes.

Results

3197 participants were included (median age 60 years). 431 participants were included (median age 70 years). Effects were consistent across prespecified subgroups.

The adjusted odds ratio was 0.38 (95% CI 0.28 to 0.63). 2877 participants were included (median age 37 years). The adjusted odds ratio was 0.68 (95% CI 0.31 to 0.65).

The adjusted odds ratio was 0.80 (95% CI 0.21 to 0.70). Effects were consistent across prespecified subgroups. The adjusted odds ratio was 0.90 (95% CI 0.40 to 0.97).

GroupnEventsRate %OR
Centre B4372335.20.70
Intervention666199.00.68
Male8891514.50.56
Control60210227.30.71
Control78210527.80.61
TABLE 1: Primary outcome by group
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Kaplan–Meier curve for 30-day readmission
Shown for adults with type 2 diabetes; error bars are 95% confidence intervals.
Figure 2
FIGURE 2: Kaplan–Meier curve for 30-day readmission
Shown for adults with type 2 diabetes; error bars are 95% confidence intervals.

30-day readmission occurred in 13% of the intervention group versus 19% of controls. 30-day readmission occurred in 10% of the intervention group versus 38% of controls. Serious adverse events were rare and similar between groups.

Discussion

Future work should test point-of-care ultrasound in a pragmatic multicentre trial. Implementation will depend on staffing, cost and local protocols. Strengths include the sample size and blinded outcome assessment.

Implementation will depend on staffing, cost and local protocols. Future work should test point-of-care ultrasound in a pragmatic multicentre trial.

Strengths include the sample size and blinded outcome assessment. Implementation will depend on staffing, cost and local protocols.

These findings suggest that point-of-care ultrasound is associated with better 30-day readmission in adults with type 2 diabetes. Residual confounding cannot be excluded. Implementation will depend on staffing, cost and local protocols.

Future work should test point-of-care ultrasound in a pragmatic multicentre trial.

Conclusions

Point-of-care ultrasound should be considered for adults with type 2 diabetes to improve 30-day readmission.

Appendices

The statistical analysis plan is in the online supplement.